MindMed Psychedelic Inspired medicines $MMEDF | Benzinga Small Cap Conference 2020

Mind Medicine (MindMed) Inc MindMed is a neuro-pharmaceutical company that discovers, develops, and deploys psychedelic inspired medicines to improve health and alleviate suffering. $MMEDF MindMed co-founder and co-CEO J.R. Rahn, as well as early backer Kevin O'Leary, Canadian businessman, investor, "Shark Tank" star and co-founder of O'Shares ETFs. Featured Guest: J.R. Rahn Co-Founder & CEO Twitter: https://twitter.com/JamonRahn Company Twitter: MindMed, which is focused on the medicinal value of psychedelics, is working to deploy alternative solutions for mental illnesses “The focus on mental health has increased geometrically,” O’Leary added. “The medicines haven’t changed in 37 years, and MindMed, alongside the whole sector, is looking for these new molecules … that don’t have such dramatic side effects, particularly when you’re dealing with young people.” Read more on our Full article: https://www.benzinga.com/general/biotech/20/11/18524487/how-mindmed-uses-tech-to-innovate-deploy-psychedelic-mental-health-therapies From The Benzinga Global Small Cap Conference 2020 Bz Small Cap Conference bridges the gap between Small Cap companies, investors, and traders. Learn about small cap investing with clearly defined educational modules, take a look at a curated group of small cap investment opportunities, and connect with the global small cap audience in an intimate, virtual setting.